Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
avelumab
Biotech
Amid pipeline woes, Celgene brings on Keytruda R&D exec
Celgene has poached a new R&D executive as it hopes to shake off past problems with a shake-up of its research unit.
Ben Adams
Oct 23, 2018 4:19am
Merck Ventures, CRUK launch new I-O spinout biotech iOnctura
Jun 20, 2017 10:25am
Pfizer, partner German Merck see FDA accept PD-L1 candidate for speedy review
Nov 29, 2016 9:47am
Merck KGaA in Transgene cancer vaccine-checkpoint inhibitor test tie-up
Oct 12, 2016 4:18am
German Merck, Vaccinex ink lung cancer anti-PD-L1 combo trial deal
Oct 7, 2016 5:31am
